Fondation de Rothschild

Futó vizsgálatok

• Még nem toboroz

  A Multicenter, Open-Label, Long-Term, Safety and Tolerability Extension Study of PTI5803 as adjunctive therapy in patients ≥ 14 years of age with drug-resistant seizures associated to focal cortical dysplasia.

  2026-525161-40-00· 2. fázis· Forrás

• Még nem toboroz

  A Phase 2a, multi centric, open label clinical study to explore the safety and tolerability, the pharmacokinetics and pharmacodynamics profile and first signs of efficacy of PTI5803 administered as adjunctive therapy with a 3-dose escalation regimen in patients >= 14 years of age with drug-resistant seizures associated to focal cortical dysplasia, followed by an optional open-label extension study.

  2026-525162-21-00· 2. fázis· Forrás

• Még nem toboroz

  Tenecteplase for the treatment of acute stroke in the late time window before inter-hospital transfer for thrombectomy: a randomized controlled trial

  2026-525280-40-00· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07465289· 3. fázis· Forrás

• Toboroz

  Efficacy of probenecid on cluster seizures during dosage reduction of Anti Seizure Medication (ASM) in presurgical focal epilepsy video-EEG monitoring

  2024-519133-29-00· 2. fázis· Forrás

• Toboroz

  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  2025-524894-17-00· 2/3. fázis· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis

  NCT07463521· 3. fázis· Forrás

• Toboroz

  A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis

  2025-521546-23-00· 3. fázis· Forrás

• Toboroz

  A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis

  NCT07067463· 3. fázis· Forrás

• Toboroz

  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  NCT07441642· 2. fázis· Forrás

• Toboroz

  Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

  NCT07325292· 3. fázis· Forrás

• Toboroz

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT07007065· 3. fázis· Forrás

• Toboroz

  Optimizing Reperfusion to Improve Outcomes and Neurologic Function (ORION)

  2024-519521-37-01· 2/3. fázis· Forrás

• Toboroz

  Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

  NCT06846281· 3. fázis· Forrás

• Toboroz

  Efficacy and Safety of Tran Cannula in Combined Pseudoexfoliative Glaucoma and Cataract Surgery Compared With Augmented Ocular Irrigation

  NCT06979752· Forrás

• Fut, nem toboroz

  A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

  NCT06957080· 2/3. fázis· Forrás

• Még nem toboroz

  Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)

  NCT06663189· 3. fázis· Forrás

• Fut, nem toboroz

  A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema)

  2024-510944-30-00· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

  NCT06558279· 3. fázis· Forrás

• Toboroz

  Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

  NCT06370182· Forrás

• Toboroz

  Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

  NCT06463587· 3. fázis· Forrás

• Toboroz

  Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to Atherosclerosis

  NCT05476991· 3. fázis· Forrás

• Toboroz

  A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)

  NCT05716100· 3. fázis· Forrás

• Meghívásos bevonás

  An Open-label Study of XEN1101 in Epilepsy

  NCT05718817· 3. fázis· Forrás

• Toboroz

  A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures

  NCT05667142· 3. fázis· Forrás

• Toboroz

  Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

  NCT05476939· 3. fázis· Forrás

• Toboroz

  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  NCT05327114· 2/3. fázis· Forrás

• Toboroz

  Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.

  NCT05050864· Forrás

• Toboroz

  Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

  NCT05105633· 2/3. fázis· Forrás

• Fut, nem toboroz

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· 3. fázis· Forrás

• Toboroz

  RESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy

  NCT04451278· Forrás

• Fut, nem toboroz

  Serum Neurofilament-light Chain and GFAP Levels in Patients From the OFSEP Cohort at Different Landmarks of Multiple Sclerosis

  NCT03981003· Forrás

• Toboroz

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  NCT03683251· 3. fázis· Forrás

• Fut, nem toboroz

  OFSEP High Definition Cohort

  NCT03603457· Forrás

• Toboroz

  Can Pretreatment MRI be Used to Predict Intra-arterial Chemotherapy Response in Retinoblastoma?

  NCT03267459· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Epilepszia7 toboroz
• Sclerosis multiplex (SM)5 toboroz
• Stroke (szélütés)5 toboroz
• Időskori makuladegeneráció4 toboroz
• Myasthenia gravis3 toboroz
• Gyermekkori daganatok2 toboroz
• Koszorúér-betegség1 toboroz
• Magas vérnyomás1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  Safety, Tolerability, and Efficacy of NVG-2089 in Participants with CIDP

  2024-515386-34-00· 2. fázis· Forrás

• Fut, nem toboroz

  A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

  NCT06744920· 3. fázis· Forrás

• Lezárult

  Reperfusion with P2Y12 inhibitors in addition to mechanical thrombectomy for perfusion imaging selected acute stroke patients : a multicentric randomized controlled trial

  NCT04667078· 4. fázis· Forrás

• Fut, nem toboroz

  A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

  NCT06517758· 3. fázis· Forrás

• Lezárult

  Efficacy and Safety of Minimally Invasive Micro-Sclerostomy (MIMS) in Glaucoma Surgery

  NCT06213805· Forrás

• Lezárult

  Glenzocimab for REperfusion in the Setting of Endovascular Therapy for Brain infarctioN: GREEN Study

  NCT05559398· 2/3. fázis· Forrás

• Lezárult

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· 3. fázis· Forrás

• Lezárult

  Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target)

  NCT04785066· 2. fázis· Forrás

• Lezárult

  Safety of Exposure to Natalizumab During Pregnancy

  NCT05209815· Forrás

• Lezárult

  A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  NCT05019521· 2. fázis· Forrás

• Lezárult

  Intelligent Evaluation of Diabetic Retinopathy

  NCT04624737· Forrás

• Lezárult

  Optical Coherence Tomography and Optic Neuritis Not Related to Multiple Sclerosis

  NCT03963310· Forrás

• Lezárult

  Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

  NCT04458051· 3. fázis· Forrás

• Lezárult

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· 2. fázis· Forrás

• Lezárult

  A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease

  NCT03819153· 3. fázis· Forrás

Vizsgálati helyszínek

• Fondation A. de Rothschild37 vizsgálat
• Fondation de Rothschild0 vizsgálat
• Fondation Rothschild8 vizsgálat
• Fondation Rothschild - service de neurologie1 vizsgálat
• Fondation A De Rothschild4 vizsgálat

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Zöldhályog (glaukóma)20 munka · 2 vizsgálat
• Időskori makuladegeneráció12 munka · 7 vizsgálat